ROBERTO F CASAL

Concepts (224)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bronchoscopy
34
2022
474
6.920
Why?
Pulmonary Atelectasis
3
2022
46
2.420
Why?
Endosonography
11
2021
536
2.390
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
11
2020
167
2.290
Why?
Lymph Nodes
14
2020
2967
1.960
Why?
Biopsy, Fine-Needle
11
2021
690
1.920
Why?
Anesthesia, General
5
2022
239
1.600
Why?
Lung Neoplasms
31
2021
11538
1.520
Why?
Image-Guided Biopsy
7
2021
327
1.340
Why?
Lung
8
2022
3151
1.310
Why?
Pleural Effusion, Malignant
9
2024
156
1.300
Why?
Cone-Beam Computed Tomography
2
2020
202
1.250
Why?
Airway Obstruction
6
2018
261
1.100
Why?
Mediastinum
9
2021
268
1.060
Why?
Stents
5
2020
1096
1.030
Why?
Lymphatic Metastasis
8
2021
4844
0.960
Why?
Thoracoscopy
6
2022
101
0.870
Why?
Embolism, Air
1
2022
33
0.850
Why?
Debridement
2
2013
123
0.840
Why?
Bronchial Diseases
2
2020
45
0.840
Why?
Laryngeal Masks
1
2022
75
0.830
Why?
Robotic Surgical Procedures
3
2022
481
0.790
Why?
Anesthetics
1
2022
115
0.780
Why?
Neoplasm Staging
14
2021
13658
0.720
Why?
Pneumonectomy
7
2019
831
0.700
Why?
Parenchymal Tissue
1
2018
8
0.670
Why?
Drainage
4
2020
416
0.660
Why?
Intraoperative Complications
2
2020
301
0.640
Why?
Autopsy
1
2018
173
0.640
Why?
Pleural Effusion
4
2024
201
0.640
Why?
Carcinoma, Non-Small-Cell Lung
10
2021
5319
0.610
Why?
Conscious Sedation
2
2015
104
0.610
Why?
Thoracentesis
5
2020
59
0.610
Why?
Air
2
2018
63
0.610
Why?
Deoxyribonucleases
2
2024
46
0.610
Why?
Catheters, Indwelling
5
2024
374
0.600
Why?
Pulmonologists
1
2017
10
0.590
Why?
Multiple Pulmonary Nodules
3
2021
59
0.560
Why?
Radiography, Interventional
1
2018
305
0.560
Why?
Lung Abscess
1
2015
13
0.550
Why?
Tomography, X-Ray Computed
11
2022
7551
0.510
Why?
Ultrasonography, Interventional
3
2014
429
0.500
Why?
Laser Therapy
1
2018
411
0.480
Why?
Hemangiosarcoma
1
2016
234
0.470
Why?
Bronchoscopes
1
2013
16
0.470
Why?
Pneumothorax
3
2020
153
0.450
Why?
Male
51
2021
123000
0.430
Why?
Equipment and Supplies
1
2012
48
0.420
Why?
Thoracic Surgery
1
2017
295
0.420
Why?
Postoperative Complications
6
2020
5542
0.420
Why?
Internet
1
2017
706
0.420
Why?
Empyema, Pleural
2
2024
48
0.410
Why?
Tracheal Neoplasms
1
2012
42
0.410
Why?
Pleura
3
2020
127
0.410
Why?
Humans
66
2024
261506
0.400
Why?
Endoscopy
1
2014
479
0.400
Why?
Neurilemmoma
1
2012
127
0.390
Why?
Aged
35
2021
70117
0.380
Why?
Esophageal Stenosis
1
2011
83
0.380
Why?
Bronchogenic Cyst
1
2010
21
0.380
Why?
Lung Diseases
2
2013
717
0.380
Why?
Tracheoesophageal Fistula
1
2011
67
0.380
Why?
Foreign-Body Migration
1
2011
117
0.370
Why?
Middle Aged
40
2021
86204
0.360
Why?
Thoracoscopes
1
2009
6
0.360
Why?
Solitary Pulmonary Nodule
2
2021
123
0.350
Why?
Surgeons
1
2017
519
0.350
Why?
Female
46
2021
141928
0.340
Why?
Catheterization
1
2011
410
0.330
Why?
Sentinel Lymph Node Biopsy
1
2015
1415
0.310
Why?
Streptococcal Infections
1
2010
280
0.310
Why?
Disease Management
1
2013
1052
0.310
Why?
Positron-Emission Tomography
2
2017
2173
0.290
Why?
Deep Sedation
2
2017
21
0.290
Why?
Thyroid Neoplasms
2
2014
1866
0.290
Why?
Bronchi
3
2017
326
0.270
Why?
Respiratory Tract Neoplasms
2
2018
37
0.260
Why?
Biopsy, Needle
3
2020
1363
0.250
Why?
Catheter Ablation
1
2010
620
0.240
Why?
Predictive Value of Tests
6
2021
4892
0.240
Why?
Thoracic Surgery, Video-Assisted
2
2017
209
0.240
Why?
Retrospective Studies
22
2024
37905
0.230
Why?
Prospective Studies
10
2022
12873
0.230
Why?
Prosthesis Design
2
2020
749
0.230
Why?
Veterans
2
2013
1641
0.230
Why?
Argon Plasma Coagulation
1
2022
6
0.220
Why?
Adenocarcinoma
3
2020
7789
0.220
Why?
Pleurodesis
4
2020
71
0.210
Why?
Feasibility Studies
4
2019
2292
0.210
Why?
Positive-Pressure Respiration
1
2022
116
0.210
Why?
Mediastinal Neoplasms
2
2015
423
0.200
Why?
Fluoroscopy
2
2021
232
0.200
Why?
Sensitivity and Specificity
5
2017
4971
0.200
Why?
Decision Trees
1
2021
178
0.190
Why?
Quality Control
2
2012
457
0.190
Why?
Esophageal Neoplasms
2
2013
3168
0.190
Why?
Equipment Design
3
2021
1204
0.190
Why?
Radiography, Thoracic
3
2020
462
0.190
Why?
Miniaturization
1
2020
47
0.180
Why?
Registries
4
2019
2170
0.180
Why?
Aged, 80 and over
13
2021
29902
0.180
Why?
Exudates and Transudates
1
2020
52
0.180
Why?
Ventilation
1
2019
20
0.180
Why?
Retreatment
1
2020
452
0.180
Why?
Incidence
4
2020
5673
0.170
Why?
Positron Emission Tomography Computed Tomography
3
2020
833
0.170
Why?
Biopsy
5
2022
3443
0.170
Why?
Constriction, Pathologic
1
2020
310
0.160
Why?
Operating Rooms
1
2019
122
0.160
Why?
Carcinoid Tumor
1
2020
280
0.160
Why?
Fiducial Markers
1
2018
96
0.160
Why?
Pleurisy
1
2017
11
0.160
Why?
Adult
18
2021
77950
0.160
Why?
Neoplasms
4
2019
15193
0.160
Why?
Suction
2
2020
104
0.150
Why?
Quality-Adjusted Life Years
2
2018
226
0.150
Why?
Device Removal
1
2020
337
0.150
Why?
Mycetoma
1
2017
10
0.150
Why?
L-Lactate Dehydrogenase
1
2018
299
0.150
Why?
Cohort Studies
7
2022
9244
0.150
Why?
Propofol
1
2017
80
0.150
Why?
Necrosis
1
2018
580
0.150
Why?
Length of Stay
3
2019
1900
0.150
Why?
Reproducibility of Results
3
2020
6009
0.150
Why?
Lymphadenopathy
1
2017
90
0.140
Why?
Instillation, Drug
1
2015
16
0.140
Why?
Thoracostomy
1
2016
43
0.140
Why?
Lung Diseases, Fungal
1
2017
124
0.140
Why?
Dyspnea
2
2018
416
0.140
Why?
Surgical Wound Infection
1
2019
450
0.140
Why?
Hypnotics and Sedatives
1
2017
218
0.140
Why?
Patient Selection
3
2021
2055
0.130
Why?
Risk Factors
8
2020
17523
0.130
Why?
Risk Assessment
4
2020
6869
0.130
Why?
Logistic Models
2
2020
3441
0.130
Why?
Treatment Outcome
10
2020
32848
0.130
Why?
Varicose Veins
1
2015
35
0.130
Why?
Superior Vena Cava Syndrome
1
2015
36
0.130
Why?
Lymphatic Diseases
1
2015
128
0.130
Why?
Palliative Care
4
2020
2037
0.120
Why?
Swine
1
2018
1541
0.120
Why?
Quality of Life
3
2018
4532
0.120
Why?
Granuloma
1
2015
154
0.120
Why?
Fatal Outcome
1
2016
829
0.120
Why?
Carcinoma, Neuroendocrine
1
2020
716
0.120
Why?
Breast Neoplasms
2
2017
15694
0.120
Why?
Ablation Techniques
1
2015
148
0.120
Why?
Hemoptysis
1
2013
36
0.120
Why?
Tracheal Diseases
1
2013
32
0.110
Why?
Contraindications
1
2013
150
0.110
Why?
Fluorodeoxyglucose F18
1
2019
1226
0.110
Why?
Trachea
1
2015
259
0.110
Why?
Bronchial Neoplasms
1
2013
79
0.110
Why?
Texas
3
2019
6311
0.110
Why?
Molecular Diagnostic Techniques
1
2014
332
0.110
Why?
Software
1
2019
1321
0.100
Why?
Radiosurgery
2
2020
1330
0.100
Why?
Minimally Invasive Surgical Procedures
2
2016
500
0.100
Why?
Single-Blind Method
1
2012
409
0.100
Why?
Silicones
1
2011
54
0.100
Why?
History, 20th Century
1
2013
574
0.090
Why?
Nervous System Diseases
1
2015
500
0.090
Why?
Early Detection of Cancer
1
2018
1258
0.090
Why?
Cost-Benefit Analysis
1
2014
945
0.090
Why?
Cytokines
1
2020
2809
0.090
Why?
Algorithms
3
2021
3890
0.090
Why?
Young Adult
9
2020
21445
0.090
Why?
Multiple Myeloma
1
2020
2138
0.090
Why?
Guideline Adherence
1
2013
636
0.090
Why?
Respiratory Tract Infections
1
2013
437
0.080
Why?
Quality of Health Care
1
2013
621
0.080
Why?
Multivariate Analysis
4
2020
4298
0.080
Why?
Chest Tubes
2
2019
101
0.080
Why?
Lymphoma
1
2015
1467
0.070
Why?
Patient Safety
1
2012
649
0.070
Why?
Thoracic Neoplasms
1
2009
337
0.070
Why?
Follow-Up Studies
3
2018
14889
0.070
Why?
Lymph Node Excision
1
2013
1959
0.070
Why?
Surveys and Questionnaires
1
2017
5687
0.060
Why?
Practice Guidelines as Topic
1
2014
2403
0.060
Why?
Carcinoma, Squamous Cell
1
2020
5437
0.060
Why?
Neoplasm Recurrence, Local
2
2022
10035
0.060
Why?
Tissue Plasminogen Activator
1
2024
163
0.050
Why?
United States
4
2021
15433
0.050
Why?
Diagnostic Imaging
1
2010
1162
0.050
Why?
Time Factors
3
2020
12926
0.050
Why?
Adolescent
6
2019
31252
0.050
Why?
Fibrinolytic Agents
1
2024
324
0.050
Why?
Recurrence
2
2020
4758
0.050
Why?
Survival Rate
4
2015
12221
0.050
Why?
Prognosis
3
2021
21713
0.050
Why?
Calibration
1
2021
337
0.050
Why?
Patient Care Management
1
2020
94
0.050
Why?
Multicenter Studies as Topic
1
2021
543
0.050
Why?
Brain Neoplasms
1
2015
4849
0.040
Why?
Survival Analysis
2
2018
9180
0.040
Why?
Recovery of Function
1
2019
703
0.030
Why?
Veterans Health
1
2017
181
0.030
Why?
Brachiocephalic Veins
1
2015
21
0.030
Why?
Pleural Neoplasms
1
2019
470
0.030
Why?
Kaplan-Meier Estimate
2
2015
6207
0.030
Why?
Bacteria
1
2019
611
0.030
Why?
Jugular Veins
1
2015
107
0.030
Why?
Pleural Cavity
1
2014
25
0.030
Why?
Intracranial Pressure
1
2015
180
0.030
Why?
Mediastinoscopy
1
2013
31
0.030
Why?
Animals
1
2018
59536
0.030
Why?
Intention to Treat Analysis
1
2012
130
0.030
Why?
ErbB Receptors
1
2020
2295
0.030
Why?
Tumor Burden
1
2017
1987
0.020
Why?
Venous Thrombosis
1
2015
384
0.020
Why?
Remission Induction
1
2015
3569
0.020
Why?
Hematologic Neoplasms
1
2019
1870
0.020
Why?
Diagnosis, Differential
1
2017
4744
0.020
Why?
Ultrasonography
1
2013
1863
0.020
Why?
Neoplasm Metastasis
1
2017
5112
0.020
Why?
Neoplasm Invasiveness
1
2014
3981
0.020
Why?
Inflammation
1
2015
2522
0.020
Why?
Proportional Hazards Models
1
2013
4988
0.020
Why?
Practice Patterns, Physicians'
1
2013
1303
0.020
Why?
Immunohistochemistry
1
2014
7548
0.010
Why?
Severity of Illness Index
1
2013
4320
0.010
Why?
Mutation
1
2020
15179
0.010
Why?
Child
1
2013
29154
0.010
Why?
CASAL's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (224)
Explore
_
Co-Authors (50)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_